S-52

N/A

Report date: 2024/12/18 10:01:43

Base Information

Drug NameS-52
Drug Alias NameS-52
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma agonistsNerve growth factor receptors agonists
TargetsAcetylcholine receptor; alpha1/beta1/delta/gammaNerve growth factor receptors
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A